TrialBritish journal of clinical pharmacology2020

First-in-human, randomized dose-escalation study of the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of PF-06480605 in healthy subjects.

Christopher Banfield et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.